These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Evidence for vasoactive intestinal peptide receptors in apical membranes from tracheal epithelium. Elgavish A, Pillion DJ, Meezan E. Life Sci; 1989 Sep; 44(15):1037-42. PubMed ID: 2538697 [Abstract] [Full Text] [Related]
43. Cholecystokinin downregulates receptors for vasoactive intestinal peptide and secretin in rat pancreatic acini. Katsushima S, Adachi H, Honda T, Sato S, Kusui T, Onishi S, Aoki E, Noguchi M, Konishi J. Am J Physiol; 1990 Mar; 258(3 Pt 1):G395-403. PubMed ID: 2156442 [Abstract] [Full Text] [Related]
44. Distribution and characterization of vasoactive intestinal polypeptide binding in canine lower esophageal sphincter. Mao YK, Wang YF, Daniel EE. Gastroenterology; 1993 Nov; 105(5):1370-7. PubMed ID: 8224641 [Abstract] [Full Text] [Related]
45. Characterization of vasoactive intestinal peptide receptors in canine liver membranes. Kiso T, Ito S, Ohta T, Asano T, Nakazato Y. Biochem Pharmacol; 1994 Jan 20; 47(2):241-5. PubMed ID: 8304967 [Abstract] [Full Text] [Related]
46. Characterization of vasoactive intestinal peptide receptors in rat seminal vesicle. Guijarro LG, Rodriguez-Pena MS, Prieto JC. Am J Physiol; 1991 Feb 20; 260(2 Pt 1):E286-91. PubMed ID: 1847588 [Abstract] [Full Text] [Related]
47. A human melanoma-derived cell line (IGR39) with a very high number of vasoactive-intestinal-peptide (VIP) receptors. 1. Molecular characterization of the binding site. Luis J, Martin JM, el Battari A, Reynier M, Marvaldi J, Pichon J. Eur J Biochem; 1989 Mar 15; 180(2):429-33. PubMed ID: 2538330 [Abstract] [Full Text] [Related]
48. Epithelial cells purified from choroid plexus have receptors for vasoactive intestinal polypeptide. Nilsson C, Fahrenkrug J, Lindvall-Axelsson M, Owman C. Brain Res; 1991 Mar 01; 542(2):241-7. PubMed ID: 1851455 [Abstract] [Full Text] [Related]
49. Vasoactive intestinal peptide in bovine pulmonary artery: localisation, function and receptor autoradiography. Barnes PJ, Cadieux A, Carstairs JR, Greenberg B, Polak JM, Rhoden K. Br J Pharmacol; 1986 Sep 01; 89(1):157-62. PubMed ID: 3026543 [Abstract] [Full Text] [Related]
50. Molecular characterization and peptide specificity of two vasoactive intestinal peptide (VIP) binding sites in the chicken pineal. Meunier AC, Voisin P, Van Camp G, Cenatiempo Y, Muller JM. Neuropeptides; 1991 May 01; 19(1):1-8. PubMed ID: 1653910 [Abstract] [Full Text] [Related]
51. Cloning and expression of the human vasoactive intestinal peptide receptor. Sreedharan SP, Robichon A, Peterson KE, Goetzl EJ. Proc Natl Acad Sci U S A; 1991 Jun 01; 88(11):4986-90. PubMed ID: 1675791 [Abstract] [Full Text] [Related]
52. Iodinated derivatives of the vasoactive intestinal polypeptide (VIP) are agonists at the cat pancreas and the rat submandibular salivary gland. Halldén G, Abens J, Engström C, Westlind A, Mutt V, Bartfai T. Regul Pept; 1986 Dec 22; 16(2):183-8. PubMed ID: 3027765 [Abstract] [Full Text] [Related]
53. Interaction of thymic peptide thymosin alpha 1 with vasoactive intestinal peptide (VIP) receptors. Calvo JR, Goberna R, Guerrero JM. Biosci Rep; 1986 Aug 22; 6(8):727-33. PubMed ID: 3028522 [Abstract] [Full Text] [Related]
54. Autoradiographic localisation of VIP receptors in human lung. Leys K, Morice AH, Madonna O, Sever PS. FEBS Lett; 1986 Apr 21; 199(2):198-202. PubMed ID: 3009219 [Abstract] [Full Text] [Related]
55. Selectivity for binding of peptide analogs to vascular receptors for vasoactive intestinal peptide. Rorstad OP, Wanke I, Coy DH, Fournier A, Huang M. Mol Pharmacol; 1990 Jun 21; 37(6):971-7. PubMed ID: 2163020 [Abstract] [Full Text] [Related]
56. Pharmacology, molecular identification and functional characteristics of vasoactive intestinal peptide receptors in human breast cancer cells. Gespach C, Bawab W, de Cremoux P, Calvo F. Cancer Res; 1988 Sep 15; 48(18):5079-83. PubMed ID: 2842044 [Abstract] [Full Text] [Related]
57. Autoradiographic study of motilin binding sites in the rabbit gastrointestinal tract. Sakai T, Satoh M, Sonobe K, Nakajima M, Shiba Y, Itoh Z. Regul Pept; 1994 Oct 21; 53(3):249-57. PubMed ID: 7846300 [Abstract] [Full Text] [Related]
58. Distribution of vasoactive intestinal peptide (VIP) and its binding sites in labial salivary glands in Sjögren's syndrome and in normal controls. Törnwall J, Uusitalo H, Hukkanen M, Sorsa T, Konttinen YT. Clin Exp Rheumatol; 1994 Oct 21; 12(3):287-92. PubMed ID: 8070162 [Abstract] [Full Text] [Related]
59. Characterization and solubilization of vasoactive intestinal peptide receptors from rat lung membranes. Provow S, Veliçelebi G. Endocrinology; 1987 Jun 21; 120(6):2442-52. PubMed ID: 3032591 [Abstract] [Full Text] [Related]
60. Vasoactive intestinal peptide and intraocular pressure: adenylate cyclase activation and binding sites for vasoactive intestinal peptide in membranes of ocular ciliary processes. Mittag TW, Tormay A, Podos SM. J Pharmacol Exp Ther; 1987 Apr 21; 241(1):230-5. PubMed ID: 3033201 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]